Patents by Inventor Gianvito Martino

Gianvito Martino has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS FOR USE IN PROGRESSIVE MULTIPLE SCLEROSIS
    Publication number: 20240148745
    Abstract: The present invention provides compounds able to induce neuroprotection of damaged neurons and boost the remyelination potential of oligodendrocytes. The compounds have been identified through methods of pharmacological screening of a small molecule library consisting of known pharmacologically active compounds and approved drugs. The screening method is also included in the invention.
    Type: Application
    Filed: March 9, 2022
    Publication date: May 9, 2024
    Applicants: FONDAZIONE CENTRO SAN RAFFAELE, INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE, ASSISTANCE PUBLIQUE HOPITAUX DE PARIS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE, SORBONNE UNIVERSITE, WESTFÄLISCHE WILHELMS-UNIVERSITÄT MÜNSTER, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, HEINRICH HEINE UNIVERSITY DÜSSELDORF, UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ, THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING / MCGILL UNIVERSITY, ISTITUTO SUPERIORE DI SANITÀ, CONSIGLIO NAZIONALE DELLE RICERCHE, IRBM S.P.A.
    Inventors: Gianvito MARTINO, Paola PANINA, Brahim NAIT-OUMESMAR, Anne BARON-VAN EVERCOOREN, Tanja KUHLMANN, Sergio BARANZINI, Norbert GOEBELS, Frauke ZIPP, Nicholas HANUSCHECK, Jack ANTEL, Cristina AGRESTI, Maria Pia ABBRACCHIO, Ivano EBERINI, Chiara PARRAVICINI, Stefania OLLA, Alberto BRESCIANI
  • AMINOGUANIDINE HYDRAZONES AS RETROMER STABILIZERS USEFUL FOR TREATING NEUROLOGICAL DISEASES
    Publication number: 20220213030
    Abstract: The present invention relates to novel aminoguanidine hydrazone-derivatives of Formula (I) which are effective as retromer stabilizers and useful as neuroprotecting drugs. The invention also relates to pharmaceutical compositions comprising the compounds and their use in therapy and diagnostic.
    Type: Application
    Filed: April 1, 2020
    Publication date: July 7, 2022
    Inventors: Gianvito MARTINO, Luca MUZIO, Nilo RIVA, Davide GORNATI, Pierfausto SENECI, Simona Carmen ELEUTERI
  • LAQUINIMOD FOR TREATMENT OF CANNABINOID RECEPTOR TYPE 1(CB1) MEDIATED DISORDERS
    Publication number: 20160310481
    Abstract: This invention provides a method of treating a human subject suffering from a CB1 receptor related disorder comprising periodically administering to the subject an effective amount of laquinimod or pharmaceutically acceptable salt thereof in an amount effective to treat the subject.
    Type: Application
    Filed: March 23, 2016
    Publication date: October 27, 2016
    Applicant: Teva Pharmaceutical Industries, Ltd.
    Inventors: Gianvito Martino, Diego Centonze
  • Laquinimod for treatment of GABA mediated disorders
    Patent number: 9161936
    Abstract: This invention provides a method of treating a subject suffering from a GABA related disorder comprising periodically administering to the subject an effective amount of laquinimod or pharmaceutically acceptable salt thereof in an amount effective to treat the subject.
    Type: Grant
    Filed: August 12, 2013
    Date of Patent: October 20, 2015
    Assignee: TEVA PHARMACEUTICAL INDUSTRIES, LTD.
    Inventors: Gianvito Martino, Diego Centonze
  • LAQUINIMOD FOR TREATMENT OF CANNABINOID RECEPTOR TYPE 1(CB1) MEDIATED DISORDERS
    Publication number: 20140045887
    Abstract: This invention provides a method of treating a human subject suffering from a CB1 receptor related disorder comprising periodically administering to the subject an effective amount of laquinimod or pharmaceutically acceptable salt thereof in an amount effective to treat the subject.
    Type: Application
    Filed: August 12, 2013
    Publication date: February 13, 2014
    Applicant: TEVA PHARMACEUTICAL INDUSTRIES, LTD.
    Inventors: Gianvito Martino, Diego Centonze
  • LAQUINIMOD FOR TREATMENT OF GABA MEDIATED DISORDERS
    Publication number: 20140045886
    Abstract: This invention provides a method of treating a subject suffering from a GABA related disorder comprising periodically administering to the subject an effective amount of laquinimod or pharmaceutically acceptable salt thereof in an amount effective to treat the subject.
    Type: Application
    Filed: August 12, 2013
    Publication date: February 13, 2014
    Applicant: TEVA PHARMACEUTICAL INDUSTRIES, LTD.
    Inventors: Gianvito Martino, Diego Centonze
  • Inflammation
    Publication number: 20080274089
    Abstract: This invention provides adult neural stem cell (aNSC) materials and methods for treating central nervous system disorders.
    Type: Application
    Filed: July 12, 2006
    Publication date: November 6, 2008
    Inventors: Stefano Pluchino, Gianvito Martino